Kathleen P. Gallagher, Officer of Atrium Therapeutics RNA, has filed 0 purchases and 12 sales on the open market. The latest trade was on 04/20.

KG

KG

Kathleen P. Gallagher

SEE REMARKS

Company

Atrium Therapeutics RNA

First filing

25/01/22

Trades

41 trades

Buys / sales

0 / 12

12-month net buying

No record

Last trade

04/20

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/09/02	25/09/02	188 sh	$47.42	$8,914.96	−0.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/06/17	25/06/18	911 sh	$30.24	$27,548.64	−1.8%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/06/02	25/06/04	5,875 sh	$32.48	$190,820	−10.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/05/01	25/05/02	5,875 sh	$32.40	$190,350	−10.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/04/01	25/04/03	5,875 sh2 trades	$27.83avg.	$163,501.25	−10.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/03/03	25/03/04	5,875 sh	$29.41	$172,783.75	−10.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/02/03	25/02/05	5,875 sh	$32.16	$188,940	−10.4%
AB Avidity Biosciences	Open-market sale10b5-1 plan	25/01/21–25/01/22	25/01/23	9,411 sh4 trades	$29.53avg.	$277,904.72	−15.7%